155 related articles for article (PubMed ID: 38543063)
1. Pharmakokinetics of Mistletoe Lectins after Intravenous Application of a Mistletoe Product in Healthy Subjects.
Lederer AK; Rieger S; Schink M; Huber R
Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543063
[TBL] [Abstract][Full Text] [Related]
2. Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Evid Based Complement Alternat Med; 2014; 2014():236310. PubMed ID: 24955100
[TBL] [Abstract][Full Text] [Related]
3. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of natural mistletoe lectins after subcutaneous injection.
Huber R; Eisenbraun J; Miletzki B; Adler M; Scheer R; Klein R; Gleiter CH
Eur J Clin Pharmacol; 2010 Sep; 66(9):889-97. PubMed ID: 20467733
[TBL] [Abstract][Full Text] [Related]
5. Safety of Combined Targeted and Helixor
Schad F; Thronicke A
Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767928
[TBL] [Abstract][Full Text] [Related]
6. Effects of mistletoe products on pharmacokinetic drug turnover by inhibition and induction of cytochrome P450 activities.
Schink M; Dehus O
BMC Complement Altern Med; 2017 Dec; 17(1):521. PubMed ID: 29202738
[TBL] [Abstract][Full Text] [Related]
7. [Helixor--mistletoe preparation for cancer therapy. Documentation No. 19].
Kast A; Hauser SP
Schweiz Rundsch Med Prax; 1990 Mar; 79(10):291-5. PubMed ID: 2180032
[TBL] [Abstract][Full Text] [Related]
8. Safety of intravenously applied mistletoe extract - results from a phase I dose escalation study in patients with advanced cancer.
Huber R; Schlodder D; Effertz C; Rieger S; Tröger W
BMC Complement Altern Med; 2017 Sep; 17(1):465. PubMed ID: 28923036
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
Felenda JE; Turek C; Stintzing FC
J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
[TBL] [Abstract][Full Text] [Related]
10. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
Stoss M; van Wely M; Musielsky H; Gorter RW
Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
[TBL] [Abstract][Full Text] [Related]
11. Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.
Urech K; Schaller G; Jäggy C
Arzneimittelforschung; 2006 Jun; 56(6A):428-34. PubMed ID: 16927522
[TBL] [Abstract][Full Text] [Related]
12. Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer.
Paller CJ; Wang L; Fu W; Kumar R; Durham JN; Azad NS; Laheru DA; Browner I; Kachhap SK; Boyapati K; Odeny T; Armstrong DK; Meyer CF; Gaillard S; Brahmer JR; Page I; Wang H; Diaz LA
Cancer Res Commun; 2023 Feb; 3(2):338-346. PubMed ID: 36860652
[TBL] [Abstract][Full Text] [Related]
13. [Lectins in Viscum:a progress review].
Li JQ; Yang B
Zhongguo Zhong Yao Za Zhi; 2021 Jul; 46(14):3551-3559. PubMed ID: 34402277
[TBL] [Abstract][Full Text] [Related]
14. Viscotoxin and lectin content in foliage and fruit of Viscum album L. on the main host trees of Hyrcanian forests.
Yousefvand S; Fattahi F; Hosseini SM; Urech K; Schaller G
Sci Rep; 2022 Jun; 12(1):10383. PubMed ID: 35725801
[TBL] [Abstract][Full Text] [Related]
15. Lectins isolated from Korean mistletoe (Viscum album coloratum) induce apoptosis in tumor cells.
Yoon TJ; Yoo YC; Kang TB; Shimazaki K; Song SK; Lee KH; Kim SH; Park CH; Azuma I; Kim JB
Cancer Lett; 1999 Feb; 136(1):33-40. PubMed ID: 10211936
[TBL] [Abstract][Full Text] [Related]
16. Long-term administration of galactoside-specific mistletoe lectin in an animal model: no protection against N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats and no induction of a relevant local cellular immune response.
Kunze E; Schulz H; Adamek M; Gabius HJ
J Cancer Res Clin Oncol; 2000 Mar; 126(3):125-38. PubMed ID: 10741906
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
Kelter G; Schierholz JM; Fischer IU; Fiebig HH
Anticancer Res; 2007; 27(1A):223-33. PubMed ID: 17352237
[TBL] [Abstract][Full Text] [Related]
18. Mistletoe (Viscum album L.) extract attenuates ıtraconazole-ınduced acute oxidative stress and hepatocellular ınjury in rats.
Çetin ES; Sozen H; Celik OI; Cigerci IH; Yılmaz N
Pak J Pharm Sci; 2023 Jan; 36(1):9-16. PubMed ID: 36967491
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.
Schad F; Atxner J; Buchwald D; Happe A; Popp S; Kröz M; Matthes H
Integr Cancer Ther; 2014 Jul; 13(4):332-40. PubMed ID: 24363283
[TBL] [Abstract][Full Text] [Related]
20. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
Gorter RW; van Wely M; Reif M; Stoss M
Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
